Key Takeaways from the BIO International Convention 2022 Nicole Brenna, US Business Development Director, represented Cromos Pharma at the BIO International Convention. Please read her key takeaways from the event. “This was my first BIO conference in person and it was great meeting Sponsors and our partners from all over the world. It was definitely nice to finally shake hands and exchange business cards,
An Unseen Cost of the Ukraine War Cromos Pharma’s CEO Vlad Bogin was interviewed by Spotlight on America as part of its investigative report on the situation with clinical trials in Ukraine. Not long-ago Ukraine was a highly attractive location for clinical trials offering numerous distinct advantages for international sponsors including: Excellent recruitment potential due to its large population of modern
Cromos Pharma Names New Head of Feasibility and Therapeutic Strategy Cromos Pharma is delighted to welcome Bulgun Margaeva to our team. Bulgun takes up the role of Head of Feasibility and Therapeutic Strategy. Skilled Clinical Research Professional Bulgun is a well-recognized specialist with over 15 years of experience in pharmaceutical industry including work at AstraZeneca, Amgen, Novartis and Roche. She gradually ascended to leadership positions, where she
